FocalPoint Arranges Growth Financing for Intravenous Therapy Services
Intravenous Therapy Services, Inc. (“ITS”), a Burbank, CA-based provider of infusion therapy and home healthcare services, has announced the successful completion of a round of financing to support its growth. This credit facility will help ITS sustain its position as one of the leading independent intravenous therapy services companies in southern California.
“We are pleased to support ITS’s growth objectives,” said Rajesh Sood, FocalPoint Managing Director. “The unique nature of healthcare financing required a creative approach and in-depth knowledge of the financing markets. The result is that ITS has obtained flexible growth capital on highly attractive terms that far exceeded management’s expectations.”
“FocalPoint was instrumental in structuring and executing a discreet while at the same time all inclusive process,” said Marcel Sassola, III, CEO of ITS. “This process allowed ITS to identify the right universe of partners willing to provide the most suitable financing for our needs.”
About Intravenous Therapy Services
Intravenous Therapy Services, Inc. is an integrated healthcare services company that provides specialty injectables, home infusion, disease specific oral medications, nursing supplies as well as skilled nursing care and consulting in southern California. ITS provides clinically progressive therapy programs including chemotherapy and IV infused medications.
FocalPoint is an independent investment bank, specializing in mergers and acquisitions, private placements (both debt and equity), and financial restructurings. The firm’s primary focus is on middle-market companies with revenues between $10 million and $250 million in a diverse range of industries.
Please feel free to contact Rajesh Sood at (818) 728-6040 with any questions about this transaction.